miproducts
ProSocial: Social Media by ProVision
ProSocial, an innovative social media platform exclusively available to ProVision members, has amassed more than 170 practice users and 20 supplier contributors since its launch in November 2024.
The social media platform supports ProVision members by providing a ready-made source of digital content representing some of the most in-demand frame and lens brands. Close to 3,000 assets are already available on the platform, which continues to expand.
In a statement ProVision described social media as “a vital channel for patient communications, brand building, and community engagement”. However, for busy practice owners, the organisation acknowledged “the demands of content creation – requiring time, creativity, and technical proficiency” can be overwhelming.
“Many independent optometrists recognise social media’s importance but struggle to manage it effectively alongside their clinical responsibilities,” said David Van Dijk, ProVision’s Campaign and Content Lead. “ProSocial alleviates this burden by providing ready-to-use, professional content that can be tweaked and personalised in seconds, not hours.”
For Brian Stevens from Brian Stevens Optometrist, in Queensland, this has proven to be the case. “ProSocial has made life much easier for planning and posting social media content on our various platforms,” he said. “Having a library of content relevant to our suppliers or current marketing campaigns saves both time and hassle.”
Curated Media
Built on the industry-leading Brandfolder platform, ProSocial is easy to use regardless of social media expertise.
The platform houses content including:
• Ready-to-share images and videos from suppliers of leading eyewear brands,
• Seasonal campaign resources like ‘End of year health fund’ and ‘Back to school eye exams’, and
• Tutorial videos that teach essential social media skills.
Additionally, in collaboration with creative agency Flabbergast, monthly content collections are available, aligned with industry events, healthcare campaigns, and seasonal trends including:
• Customisable posts that tie into holiday periods,
• Healthcare awareness posts,
• Industry news and trending topics, and
• Seasonal eye care tips and advice.
The monthly content collections enable practices to strategically schedule weeks, or even months, of social media posts, while minimising the effort required for content planning and creation.
For further information visit: optom.provision.com.au/ProSocial
Eikance 0.01%
Eikance 0.01%, the first pharmacotherapy registered on the Australian Register of Therapeutic Goods to slow the progression of myopia in children aged 4–14 years,1# may be initiated in children when myopia progresses ≥-1.0 D per year.1
Eikance 0.01% single-use ampoules are sealed in foil pouches and are available in packs of 30 x 0.3 mL ampoules. The ophthalmic solution is sterile and preservative-free. Eikance 0.01% is a prescription only medicine available at community pharmacies across Australia.
Contact: Aspen Account Manager
PBS information: This product is not listed on the PBS
Before prescribing please review full product information on page 2 of this issue of mivision, or scan code (right) to access product information.
This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at: tga.gov.au/reporting-problems.
Reference
1. Eikance Approved Product Information # Australian Register of Therapeutic Goods. Accessed: 11 March 2024.
Aspen Australia, St Leonards NSW 2065. AU-ATR-032024-08305